Gregory Morton PhD - Expanded Publication List

Baskin DG, Kim F, Gelling RW, Russell BJ, Schwartz MW, Morton GJ, Simhan HN, Moralejo DH and Blevins JE. A new oxytocin-saporin cytotoxin for lesioning oxytocin-receptive neurons in the rat hindbrain. Endocrinology. In Press.

Sarruf DA, Thaler JP, Morton GJ, German J, Fischer JD, Ogimoto K and Schwartz MW.  FGF21 acts in the brain to increase energy expenditure and insulin sensitivity. Diabetes. 2010 Mar 31 [Epub ahead of print].

Shinsuke Oh-I, Thaler JP, Ogimoto K, Wisse BE, Morton GJ and Schwartz MW.  Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high fat feeding. Am J Physiol Endocrinol Metab. 2010 Apr 6 [Epub ahead of print].

Kaiyala KJ, Morton GJ, Leroux B, Ogimoto K and Schwartz MW.  Relative contributions of fat and lean mass to murine metabolic rate. Diabetes. 2010 Apr 22 [Epub ahead of print].

Ellacott KLJ, Morton GJ, Woods SC, Tso P and Schwartz MW.  Assessment of feeding behavior in laboratory mice. Cell Metabolism. In Press.

Ayala JE, Samuel VT, Morton GJ, Obici S, Croniger CM, Shulman GI, Wasserman DH and McGuinness. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Disease Models and Mechanisms. In Press.

Kim, F., Pham, M., Maloney, E., Rizzo, N.O., Morton, G.J., Wisse, B.E., Kirk, E.A., Chait, A., and Schwartz, M.W. Vascular Inflammation, Insulin Resistance, and Reduced Nitric Oxide Production Precede the Onset of Peripheral Insulin Resistance. Arterioscler Thromb Vasc Biol. 28:1982-1988, 2008.

Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S., and Schwartz, M.W. Central nervous system control of food intake and body weight. Nature. 443:289-295, 2006.

Kaelin, C.B., Gong, L., Xu, A.W., Yao, F., Hockman, K., Morton, G.J., Schwartz, M.W., Barsh, G.S., and MacKenzie, R.G. Signal transducer and activator of transcription (stat) binding sites but not stat3 are required for fasting-induced transcription of agouti-related protein messenger ribonucleic acid. Mol Endocrinol. 20:2591-2602, 2006.

Gelling, R.W., Morton, G.J., Morrison, C.D., Niswender, K.D., Myers, M.G., Jr., Rhodes, C.J., and Schwartz, M.W. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab. 3:67-73, 2006.

Morton, G.J., Blevins, J.E., Williams, D.L., Niswender, K.D., Gelling, R.W., Rhodes, C.J., Baskin, D.G., and Schwartz, M.W. Leptin action in the forebrain regulates the hindbrain response to satiety signals. J Clin Invest. 115:703-710, 2005.

Morton, G.J., Gelling, R.W., Niswender, K.D., Morrison, C.D., Rhodes, C.J., and Schwartz, M.W. Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab. 2:411-420, 2005.

Morton, G.J., Mystkowski, P., Matsumoto, A.M., and Schwartz, M.W. Increased hypothalamic melanin concentrating hormone gene expression during energy restriction involves a melanocortin-independent, estrogen-sensitive mechanism. Peptides. 25:667-674, 2004.

Morrison, C.D., Morton, G.J., Niswender, K.D., Gelling, R.W., and Schwartz, M.W. Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. Am J Physiol Endocrinol Metab. 289:E1051-1057, 2005.

Morton, G.J., Niswender, K.D., Rhodes, C.J., Myers, M.G., Jr., Blevins, J.E., Baskin, D.G., and Schwartz, M.W. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats. Endocrinology. 144:2016-2024, 2003.

Niswender, K.D., Morton, G.J., Stearns, W.H., Rhodes, C.J., Myers, M.G., Jr., and Schwartz, M.W. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature. 413:794-795, 2001.